Journal article icon

Journal article

Toward control? The prospects and challenges of typhoid conjugate vaccine introduction

Abstract:
With a newly World Health Organization (WHO)–prequalified typhoid conjugate vaccine (TCV), Gavi funding for eligible countries, and a WHO policy recommendation for TCV use, now is the time for countries to introduce TCVs as part of an integrated typhoid control program, particularly in light of the increasing burden of antimicrobial resistance. Continued vaccine development efforts will lead to secure supply of low-cost vaccines, and ongoing vaccine studies will provide critical vaccine performance data and inform optimal deployment strategies, in both routine use and in outbreak settings. TCV programs should include thoughtful communication planning and community engagement to counter vaccine hesitancy.
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Publisher copy:
10.1093/cid/ciz483

Authors


More by this author
Institution:
University of Oxford
Division:
HUMS
Department:
History Faculty
Role:
Author
ORCID:
0000-0002-0055-3460


Publisher:
Oxford University Press
Journal:
Clinical Infectious Diseases More from this journal
Volume:
69
Issue:
S5
Pages:
S408-S411
Publication date:
2019-10-15
Acceptance date:
2019-09-20
DOI:
EISSN:
1537-6591
ISSN:
1058-4838
Pmid:
31612940


Language:
English
Keywords:
Pubs id:
1064242
Local pid:
pubs:1064242
Deposit date:
2020-02-28

Terms of use



Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP